compounds revealed that the structure of phepropeptin B was cyc/o(-L-Leu-D-Phe-L-Pro-L-Phe-D-Leu-L-Val-). The phepropeptins
showed inhibition to the proteasomal chymotrypsin-like activity but not to a-chymotrypsin.
Proteasome is the multicatalytic protease complex with chymotrypsin-like (ChT-L), trypsin-like (T-L), peptidyl glutamyl peptide hydrolase (PGPH), branched chain amino acid preferring (BrAAP), and small neutral amino acid preferring (SNAAP) activities1>2) responsible for the degradation of the functional proteins used for cell cycle progression, immune responses, and inflammation depending on ubiquitin in the presence of ATP3~5). Because proteasome regulates manyimportant functions in cellular events, a proteasome inhibitor is considered to be useful for therapeutic applications6'7Ŝ ynthetic peptides including PS-3417) and natural products such as Iactacystin8'9) and epoxomicin10) which suppress tumor growth and regulate antigen presentation1 1}, respectively, have been reported as proteasome inhibitors.
A mechanistic analysis of the lactacystin and peptide aldehyde inhibitors revealed that their mechanism of inhibition is the inhibitory binding to the amino terminal threonine residue of the proteasomal /J-subunit which catalyzes the ChT-L activity9'n\ Though this research indicated that the inhibition of the ChT-L activity is efficient toward the major catalytic activities of proteasome, i t has been considered that other types of inhibitors could affect the cellular responses in different ways13). pp.874 -881 We then screened new inhibitors of proteasome in microbial secondary metabolites and isolated four related inhibitors, named phepropeptins A, B, C, and D ( Fig. 1 ), as products of Streptomyces sp. MK600-cF7. Their structures were determined as cyclic hexapeptides and we determined the stereochemistry of the phepropeptins based on an amino acids analysis and synthetic study. Wedescribed the isolation procedure, structural determination including stereochemistry, and proteasome inhibition of the phepropeptins in this report.
Materials and Methods

ProteasomePreparation
The proteasome used in this study was partially purified from mouse livers as follows. A 7.3 g sample of livers from five mice were homogenized in 20ml of homogenizing buffer consisting of 50mM Tris-HCl (pH 7.5), 1mM dithiothreitol (DTT), 2mM ATP, 0.25m sucrose and ultracentrifuged at 35,000rpm for 1hour at 4°C. The supernatant was then further ultracentrifuged at 40,000 rpm for ,5hours at 4°C. The obtained precipitate of this centrifugal fractionation was resolved in 2 ml of standard buffer consisting of 25mMTris-HCl (pH 7.5), 1 him DTT, 2mMATP, 20% glycerol and centrifuged at 20,000 g for 30 minutes to remove any insoluble particles. The supernatant was divided and stored at -20°C as the proteasome preparation.
Peptidase Assay The peptidase activity of proteasome was represented as the ChT-L activity using a fluorogenic substrate, Suc-LeuLeu-Val-Tyr-MCA (Peptide Institute, Inc., Osaka). Briefly, 80/ll of the total reaction mixture containing 50mM Tris-HCl (pH 8.0), 1him-DTT, 2mM ATP, 0.05% (w/v) SDS, 20/xm fluorogenic substrate and the proteasome preparation described above was incubated for 30 minutes at 37°C. The reaction was stopped by the addition of 50ji\ of 10% (w/v) SDSsolution, and then the fluorescence of the released aminomethylcoumarin was measured. To measure the proteasomal T-L and PGPH activities, the fluorogenic substrates were replaced by Boc-Leu-Arg-Arg-MCA and Z-Leu-Leu-Glu-MCA (Peptide Institute, Inc., Osaka), respectively, and SDS was not added during the reaction whenmeasuring the T-L activity.
Fermentati on
The MK600-cF7 strain identified as Streptomyces sp.
was inoculated into a 500-ml Erlenmayer flask containing 110ml of medium consisting of 2.5% soybean meal, 2% soybean oil, 1% maltose, 0.2% yeast extract, 0.05% K2HPO4 and 0.025% MgSO4. The flask for the seed culture was shaken on a rotary shaker for 5 days at 27°C. Two ml portions were inoculated into 500-ml Sakaguchi flasks containing 125ml of the same medium into 40 of 500-ml Sakaguchi. These flasks were reciprocated for 5 days at 27°C.
Amino Acids Analysis A 56 mg sample of2 was hydrolyzed in 4ml of6n HC1 at 105°C for 22 hours. The hydrolysate was dried, resolved in 5ml of 0.05 m pyridine-HCOOH (pH 3.1) and charged on an ion exchanging column (Dowex 50WX8,200-400 mesh, 21 mmi.d.X400mm) equilibrated with the same buffer. The column was eluted with the following buffer systems, 0.1 M pyridine-HCOOH (pH 3.1) for proline, 0.2 m pyridine-HCOOH (pH 3.1) for valine, and 0.2 m pyridineAcOH (pH 3.1) for leucine and phenylalanine (18.3mg) separately in that order. To further purify the proline, valine Scheme 1. Synthetic route of2 and its stereoisomer.
and leucine, each fraction was charged on a column (Dowex 50WX4, 50-100 mesh, 20mmi.d.X60mm) and eluted with In NH4OHto give proline (9.2mg), valine (7.4 mg), and leucine (6.6 mg), respectively. 1 was hydrolyzed and the constituent amino acids were similarly separated.
The configurations of the resulting amino acids were analyzed by thin layer chromatography on an HPLC-chiral plate (Art. 14101, Merck) with the solvent system of MeOH-CH3CN-H2O, 1 :4 : 1 (in volume).
Synthesis of 2 and Its Stereoisomer
The syntheses of 2 and its stereoisomer were summarized in Scheme 1. Briefly, the Boc tripeptide benzyl Fragment condensation of these tripeptide acids and amino-ester hydrochloride derivatives using Bop/HOBt in the presence of triethylamine afforded the Boc-hexapeptide benzyl esters in 90-95% yield.
After deprotection by hydrogenation with palladium black, The Boc-hexapeptide benzyl esters were treated with 4n HCl/dioxane to yield the corresponding hexapeptide hydrochloride. Cyclization of the hexapeptide was fulfilled using diphenylphosphoryl azide and sodium bicarbonate (DPPA/NaHCO3) in DMF(15ml per lOOmg peptide) at 5°C for 3 days in 30-40% yield. (s). The retention time was 5.9 minutes, (under the same conditions described in Table 1) .
: MP 125~127°C, [aft3 -107.4°(c 1.1, MeOH), Chemical shifts of *H-and 13C-NMR (ppm in CDC13) were identical with those of 2. The retention time was 8.1 minutes, (under the same conditions described in Table 1 ).
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Melting points were determined with a Yanagimoto micro-melting point apparatus and are uncorrected. Optical rotations were measured with a Perkin-Elmer 241 polarimeter. Mass spectra were obtained using a JEOL JMS-SX102spectrometer. All NMRspectra were recorded with a JEOL JNM-A500 spectrometer at 500 MHz (*H) and 125MHz (13C) in CDC13. The fluorescence of AMCwas measured by a Millipore CytoFluor 2300 fluorometer with filters of360 nm (ex) and 460 nm (em).
Results and Discussion
Isolation
The fermented broth of the producing strain described above was centrifuged to separate the mycelium. The mycelium cake was extracted with 2 liters of MeOHand filtered to remove any insoluble materials. The filtrate was concentrated in vacuo and combined with the broth filtrate. This material (5 liter) was extracted with EtOAc and the organic layer was evaporated to dryness to give 19.4 g of an oily residue. This residue was suspended in 200ml of MeOHand extracted with 400ml of hexane. The crude material (10.9 g) that resided in the methanolic phase was charged on a silica gel column (Wako Gel C-200, 40mm i.d.Xl60mm) and eluted with 400ml each of the solvent mixture of CHCl3-MeOH (100:0, 100: 1, 100:2). The fractions containing the phepropeptins were collected and dried to give 2.78g of an oily residue. This material was 
Structural Analysis
The physico-chemical properties of the phepropeptins are shown in Table 1 . The phepropeptins as white powders NOV. 2001 were soluble in MeOH, CHC13, or EtOAc, and insoluble in hexane and H2O. Their IR absorption bands at 1641 cm"1 and 1514-1516cm"1 suggested that the phepropeptins were peptide substances. The UV spectra of the phepropeptins suggested that the presence of a benzyl group (slight absorption around 258 nm) originated from the Phe moiety.
The 1H-and 13C-NMRdata of the phepropeptins are shown in Tables 2 and 3 , respectively. The results of the 1H-*H COSYand HMBC experiments of 4 are summarized in reported. The constituent amino acids were properly numbered in Roman numerals, described in the Fig. 2 inset, and used in Tables 2 and 3 . Next, we analyzed the configurations of the constituent amino acids of the phepropeptins. We decomposed 1 and 2, which differ only in the amino acid next to Pro, and the Rf values of the amino acids separated from the hydrolysates of 1 and 2 are shown in 
toward the ChT-L activities were l S.O^g/ml and 1 1.0 jUg/ml, respectively. These observations
identical to the properties of natural 2. Hence, it has revealed that the absolute structure of 2 is cyc/o(-L-Leu-DPhe-L-Pro-L-Phe-D-Leu-L-Val-).
Based on these results, we determined that the absolute structures of the phepropeptins
where X is Leu for 1 and 3, Phe for 2 and 4, whereas Y is Val for 1 and 2, Hefor3 and4.
Inhibition of Proteasome
The inhibitory activities to proteasome by the phepropeptins are shown in Table 5 Table 5 . Inhibitory activities to proteasome.
which have been shown to bind to the j3-subunits of proteasome, in that, as small, stable, cyclic peptides, the phepropeptins are unlikely to react with the enzymes.
Given that the proteasomes are believed, via their multicatalytic activities, to regulate some important, but undefined, cellular activities, the phepropeptins may contribute to the development of new therapeutic or biochemical tools.
